Ozempic®

Ozempic® is an FDA-approved branded Semaglutide medication used in appropriate patients based on its approved clinical indications. Semaglutide is a GLP-1 receptor agonist involved in glucose-dependent insulin secretion, glucagon regulation, appetite signaling, and metabolic function. Through MEDVera, Ozempic® may be considered when clinically appropriate after licensed provider review. Treatment decisions are based on medical history, current medications, metabolic health factors, contraindication screening, and individualized clinician judgment.